ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,674Medicare Part D Prescriptions Filled, Including Refills

Rank: 107 out of 1802

$517K Total Retail Price of All Prescriptions

Rank: 84 out of 1802

393 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
60% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Wisconsin
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 393 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

11% of this provider’s 393 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

0% of this provider’s 7,537 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Wisconsin
WARFARIN SODIUM 424 411 1 7
LISINOPRIL 345 299 2 3
AMLODIPINE BESYLATE 286 268 3 6
SIMVASTATIN 269 237 4 1
BUMETANIDE 261 260 5 102
LEVOTHYROXINE SODIUM 254 209 6 2
CARVEDILOL 234 198 7 36
FUROSEMIDE 171 153 8 5
CITALOPRAM HBR 165 165 9 17
HYDROCHLOROTHIAZIDE 160 140 10 8
HYDROCODONE-ACETAMINOPHEN 160 153 S3 10 10
METOPROLOL TARTRATE 157 152 12 9
OMEPRAZOLE 145 126 13 4
SERTRALINE HCL 143 143 14 20
METFORMIN HCL 140 112 15 11
CRESTOR 125 79 16 31
LOSARTAN POTASSIUM 102 85 17 18
POTASSIUM CHLORIDE 100 96 18 15
LANTUS 96 74 19 47
METOPROLOL SUCCINATE 95 81 20 13
FENTANYL 91 84 S2 21 43
DIVALPROEX SODIUM 89 89 22 74
TRAZODONE HCL 87 64 23 39
LISINOPRIL-HYDROCHLOROTHIAZIDE 84 60 24 23
JANUVIA 82 75 25 76
QUETIAPINE FUMARATE 81 77 26 54
RANITIDINE HCL 80 65 27 30
MIRTAZAPINE 79 78 28 38
TRAMADOL HCL 77 75 29 22
OXYCODONE HCL 74 69 S2 30 41
ALLOPURINOL 72 72 31 24
PRAVASTATIN SODIUM 72 64 31 19
GABAPENTIN 71 35 33 16
FENOFIBRATE 69 58 34 56
CHLORTHALIDONE 69 56 34 121
RENACIDIN 69 69 10 34 305
ADVAIR DISKUS 67 50 37 32
RISPERIDONE 62 62 38 64
LOVASTATIN 61 56 39 25
FLUOXETINE HCL 59 36 40 35
PREDNISONE 57 50 41 33
SEROQUEL 55 52 42 128
ROPINIROLE HCL 54 41 43 89
DONEPEZIL HCL 54 54 43 26
INDAPAMIDE 53 53 45 189
TAMSULOSIN HCL 50 50 46 28
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.